Previous studies suggested that decreased NCOR2 expression promotes breast cancer initiation and progression by acting as a corepressor of estrogen receptor (ER), which has been shown to play an important role in the growth of breast cancer (28). Here, NCOR2 is linked to breast carcinoma.